News

Neurosteroids identified as potential therapy for treatment-resistant depression
Depression, characterized by persistent sadness, hopelessness and a lack of interest in previously enjoyed activities, is one ...
The Vindicator5h
Why patients should care about FDA cutbacks
How do doctors, nurse practitioners, physician associates, pharmacists and patients learn about drug side effects? The most comprehensive source for such data comes from the official prescribing ...
UW-Madison center sees promise in using psychedelics for addiction, PTSD, depression
Far removed from the negative attention such drugs used to get, the hope is that they help people find answers within ...
Fierce Healthcare13d
Virtual depression and anxiety programs prove effective but costs vary wildly, PHTI finds
An independent analysis found virtual mental health solutions for depression and anxiety effectively treat the conditions, ...
The Heartland Institute6d
FDA to Phase Out Synthetic Food Dyes
The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) plan to phase out all ...
FDA won’t approve COVID shot for healthy, non-elderly population
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
FDA steps away from COVID vaccines for healthy adults under 65
Healthy adults younger than 65 will no longer be eligible for COVID-19 shots starting in the fall, according to new federal ...
FDA announces plans to restrict access for COVID vaccines
For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.